Article
Depression, inflammation, and epidermal growth factor receptor (EGFR) status in metastatic non-small cell lung cancer: A pilot study.
Journal of psychosomatic research - 1 Aug 2017
Jacobs Jamie M, Traeger Lara, Eusebio Justin, Simon Naomi M, Sequist Lecia V, Greer Joseph A, Temel Jennifer S, Pirl William F
Abstract excerpt
OBJECTIVE: Patients with stage IV non-small cell lung cancer (NSCLC) have high risk for depressive symptoms and major depressive disorder (MDD); however, those with epidermal growth factor receptor (EGFR) mutations may have decreased risk. The biological underpinning of this relationship is unknown. We examined differences in depression severity and MDD in patients with newly diagnosed stage IV NSCLC based on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
